
Bausch Health Companies (BHC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bausch Health Companies (BHC) last issued guidance on October 28, 2026 for fiscal year 2026. The company guided revenue in the range of $10.97B - $11.18B for the period.
Compared to prior guidance, Bausch Health Companies raised its revenue forecast from a prior range of $10.79B - $11.04B.
Bausch Health Companies has issued 18 guidance updates between November 3, 2022 and October 28, 2026. During this period, the company raised its outlook 9 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.21 | $1.01 | $0.72 | $1.24 |
| Actual | $1.77 | $1.26 | $0.78 | $1.10 |
| Surprise | +46.3% | +24.8% | +8.33% | -11.3% |
| Revenue | ||||
| Estimate | $2.75B | $2.66B | $2.41B | $2.70B |
| Actual | $2.94B | $2.85B | $2.52B | $2.80B |
| Surprise | +6.79% | +7.37% | +4.82% | +3.38% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $1.26 | $0.86 |
| Revenue | ||
| Consensus | $2.80B | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $1.77 | $1.21 | 46.3 % |
| Q2 | Jul 29, 2026 | $1.26 | $1.01 | 24.8 % |
| Q1 | Apr 29, 2026 | $0.78 | $0.72 | 8.33 % |
| Q4 | Feb 18, 2026 | $1.10 | $1.24 | -11.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $2.94B | $2.75B | 6.79 % |
| Q2 | Jul 29, 2026 | $2.85B | $2.66B | 7.37 % |
| Q1 | Apr 29, 2026 | $2.52B | $2.41B | 4.82 % |
| Q4 | Feb 18, 2026 | $2.80B | $2.70B | 3.38 % |